https://www.businesswire.com/news/home/20200318005705/en/
New Research Identifies Potential Treatment for Nervous System Dysfunction in Lupus Patients
Our results indicate that GluN2A-specific antagonists or negative allosteric modulators are strong candidates to treat SLE patients with nervous system dysfunction.
